GeneNews Limited

(GLRE)

By |

Profile

GeneNews Ltd is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications.

Contact Information

Website: www.genenews.com
Email: contact@genenews.com
Main Phone: +1 905 209-2030
Address: 445 Apple Creek Boulevard
Address 2: Suite 220
State: ON
City / Town: Markham
Country: CAN
Postal Code: L3R 9X7

Issuer Information

Exchange: TSX
CEO: James R. Howard-Tripp
Employees: 18
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
$ 14.00 $ -0.15 (-1.06%)
Last Price 14.00 Change $ -0.15 Change % -1.06 Tick N/A
Bid N/A Bid Size 0.00 Ask 14.70 Ask Size 100.00
Open 14.05 High 14.13 Low 13.80 Prev Close 14.15
Last Trade Volume 217,490 52 Wk Hi 23.15 52 Wk Low 13.55
Market Cap 525.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,538,613.00 EPS (TTM) -5.29 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 11 36
Number of Buys 9 23
Number of Sells 2 13
Net Activity 21720 146985
Last 10 Buys Shares
Leonard Goldberg 1,000
Leonard Goldberg 1,000
Daniel Roitman 1,000
Daniel Roitman 1,000
Daniel Roitman 1,000
Daniel Roitman 1,000
Daniel Roitman 1,000
Leonard Goldberg 1,000
Daniel Roitman 1,000
Daniel Roitman 1,000
Last 10 Sell Shares
Barry Brendan 1,000
Barry Brendan 1,000
Romer Faramarz 1,000
Laura Accurso 1,000
Romer Faramarz 1,000
Diaz Sherry 1,000
Leonard Goldberg 1,000
Diaz Sherry 1,000
Leonard Goldberg 1,000
Leonard Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 25 25 25 25
Low Target Price Estimate 25 25 25 25
Mean Target Price Estimate 25 25 25 25
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/23/18 02/23/18 02/23/18 02/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1